Categories AlphaGraphs, Health Care

Poly Medicure Q1 FY26 Earnings Results

Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices. Presenting below are its Q1 FY26 earnings results.

 

Q1 FY26 Earnings Results

  • Total Income: ₹403 crores, up 4.68% YoY (Q1 FY25: ₹385 crores) and up 13.2% QoQ (Q4 FY25: ₹393.05 crores).

  • Total Expenses: ₹323.28 crores, up 6.28% YoY.

  • Profit Before Tax (PBT): ₹121.62 crores, up 23.5% YoY (Q1 FY25: ₹98.46 crores) and up 31.5% QoQ.

  • Profit After Tax (PAT): ₹93.08 crores, up 25.68% YoY (Q1 FY25: ₹74.04 crores), up 36.2% QoQ.

  • Earnings Per Share (EPS): ₹9.19, up 19.2% YoY (Q1 FY25: ₹7.70).

  • Operating EBITDA Margin: 26.3% in Q1 FY26.

  • PAT Margin: 20.9%, expanded by ~250bps YoY.

  • Domestic Revenue: Grew 20.1% YoY, reflecting strong traction.

  • International Revenue: Contributes ~70% of total, declined 0.9% YoY due to short-term demand and tariff issues.

 

Management Commentary & Strategic Decisions

  • Management emphasized continued strong domestic momentum, healthy margins, and enhanced PAT even as global geopolitical/trade headwinds impacted exports in the quarter.

  • The company maintains zero net debt with liquidity of ₹1,248.6 crore, and CapEx of ₹95 crore in Q1 to build infrastructure for future growth.

  • Critical Care, Cardiology, and Renal Divisions continue robust expansion, positioning Poly Medicure strongly for future opportunities across therapies and geographies.

  • Management expects 5–10% international business growth in coming quarters, supported by ongoing product innovation and sustainability focus.

  • Production capacity exceeds 1.8 billion devices annually, with a diverse portfolio over 12 therapy areas and 125+ export markets.

 

Poly Medicure Q1 FY26 Earnings Results

 

Q4 FY25 Earnings Results

  • Total Income: ₹441 crores.

  • Total Expenses: ₹321 crores.

  • PBT: ₹92.46 crores.

  • PAT: ₹92 crores.

  • EPS: ₹9.06

 

To view the company’s previous earnings and latest concall transcripts, click here  to visit the Alphastreet India news channel.

Most Popular

Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript

Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah

All you need to know about Antony Waste Handling Cell in one article

Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?

Demystifying the Leading Non-Ferrous Recycling Company of India

“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,

Top